Delivery of RNA interference

被引:163
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [11] Delivery Systems for RNA Interference Therapy: Current Technologies and Limitations
    Wang, Yi
    CURRENT GENE THERAPY, 2020, 20 (05) : 356 - 372
  • [12] RNA interference-based therapy and its delivery systems
    Xiuhui Chen
    Lingegowda S. Mangala
    Cristian Rodriguez-Aguayo
    Xianchao Kong
    Gabriel Lopez-Berestein
    Anil K. Sood
    Cancer and Metastasis Reviews, 2018, 37 : 107 - 124
  • [13] Dendrimer-Based RNA Interference Delivery for Cancer Therapy
    Xu, Leyuan
    Yeudall, W. Andrew
    Yang, Hu
    TAILORED POLYMER ARCHITECTURES FOR PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS, 2013, 1135 : 197 - 213
  • [14] RNA interference in neuroscience
    Genc, S
    Koroglu, TF
    Genc, K
    MOLECULAR BRAIN RESEARCH, 2004, 132 (02): : 260 - 270
  • [15] RNA interference-based therapy and its delivery systems
    Chen, Xiuhui
    Mangala, Lingegowda S.
    Rodriguez-Aguayo, Cristian
    Kong, Xianchao
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    CANCER AND METASTASIS REVIEWS, 2018, 37 (01) : 107 - 124
  • [16] Targeted delivery methods for RNA interference are necessary to obtain a potential functional cure for HIV/AIDS
    Cisneros, Ethan
    Sherwani, Najia
    Lanier, Olivia L.
    Peppas, Nicholas A.
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 199
  • [17] Polycation-based nanoparticle delivery for improved RNA interference therapeutics
    Howard, Kenneth A.
    Kjems, Jorgen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1811 - 1822
  • [18] Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro
    Ramachandran, Shyam
    Krishnamurthy, Sateesh
    Jacobi, Ashley M.
    Wohlford-Lenane, Christine
    Behlke, Mark A.
    Davidson, Beverly L.
    McCray, Paul B., Jr.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2013, 305 (01) : L23 - L32
  • [19] RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise
    Das, Manisit
    Musetti, Sara
    Huang, Leaf
    NUCLEIC ACID THERAPEUTICS, 2019, 29 (02) : 61 - 66
  • [20] Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies
    Wang, Leo L.
    Burdick, Jason A.
    ADVANCED HEALTHCARE MATERIALS, 2017, 6 (01)